Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.44M 1.33M 1.24M 2.32M 155M 2.34M 15.75M 6.12M 76.23M 6.16M 6.03M 265M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.11M 6.57M 6.14M 11.51M 770M 11.61M 78.06M 30.34M 378M 30.52M 29.86M 1.31B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-99.50%-.--% - - 3.65K
+0.32%-2.73%+44.49%+143.28% 980B
+1.27%-3.98%+54.41%+41.13% 550B
+6.25%+1.00%+24.13%+68.06% 382B
+0.25%-3.09%+23.33%+16.78% 316B
+0.42%-1.28%+27.89%+14.71% 272B
+1.67%-1.47%+26.76%+32.88% 268B
+2.39%+4.42%-36.96%-45.12% 199B
+2.11%-2.95%+19.14%+51.83% 182B
+0.90%-0.57%+15.09%+60.89% 154B
Average -9.18%-2.70%+22.03%+42.72% 366.93B
Weighted average by Cap. +0.51%-3.50%+31.28%+65.69%

Financials

2007 2008
Net sales 23.47M 20.54M 18.98M 17.71M 33.23M 2.22B 33.52M 225M 87.57M 1.09B 88.1M 86.19M 3.79B 25.96M 22.72M 20.99M 19.59M 36.76M 2.46B 37.08M 249M 96.88M 1.21B 97.46M 95.34M 4.2B
Net income -20.86M -18.25M -16.87M -15.74M -29.54M -1.97B -29.79M -200M -77.84M -969M -78.3M -76.61M -3.37B -4.01M -3.51M -3.24M -3.02M -5.67M -379M -5.72M -38.47M -14.95M -186M -15.04M -14.71M -647M
Net Debt 18.79M 16.44M 15.19M 14.18M 26.61M 1.78B 26.84M 180M 70.12M 873M 70.54M 69.01M 3.04B 6.49M 5.68M 5.25M 4.9M 9.19M 614M 9.27M 62.31M 24.21M 301M 24.36M 23.83M 1.05B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!